Philip A. Iredale

1.4k total citations
30 papers, 1.1k citations indexed

About

Philip A. Iredale is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Philip A. Iredale has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Philip A. Iredale's work include Neuroscience and Neuropharmacology Research (13 papers), Cannabis and Cannabinoid Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Philip A. Iredale is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Cannabis and Cannabinoid Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Philip A. Iredale collaborates with scholars based in United States, United Kingdom and Japan. Philip A. Iredale's co-authors include Stephen J. Hill, Ronald S. Duman, Rose Z. Terwilliger, Eric J. Nestler, Stephen J. Gold, Ni Yan, John R. Hadcock, David A. Griffith, S P H Alexander and Aron H. Lichtman and has published in prestigious journals such as Journal of Neuroscience, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Philip A. Iredale

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip A. Iredale United States	18	511	464	229	197	120	30	1.1k
Karla Drescher Germany	17	607 1.2×	488 1.1×	166 0.7×	54 0.3×	51 0.4×	31	1.0k
Philip L. Mobley United States	19	620 1.2×	537 1.2×	215 0.9×	185 0.9×	77 0.6×	31	1.2k
Erik I. Charych United States	15	492 1.0×	747 1.6×	164 0.7×	169 0.9×	48 0.4×	18	1.3k
Ayhan Şık Netherlands	10	445 0.9×	585 1.3×	341 1.5×	67 0.3×	152 1.3×	10	1.1k
Clotilde Mannoury la Cour France	26	1.2k 2.3×	993 2.1×	211 0.9×	131 0.7×	187 1.6×	48	1.9k
Linda H. Fossom United States	19	571 1.1×	536 1.2×	101 0.4×	75 0.4×	40 0.3×	32	1.0k
M.B. Emerit France	25	1.4k 2.7×	1.2k 2.7×	124 0.5×	65 0.3×	148 1.2×	49	2.1k
Agata Faron‐Górecka Poland	21	632 1.2×	464 1.0×	158 0.7×	222 1.1×	102 0.8×	77	1.1k
Ludo Kennis Belgium	7	555 1.1×	537 1.2×	102 0.4×	90 0.5×	94 0.8×	12	1.1k
Holger Rosenbrock Germany	23	512 1.0×	525 1.1×	264 1.2×	104 0.5×	68 0.6×	62	1.2k

Countries citing papers authored by Philip A. Iredale

Since Specialization

Citations

This map shows the geographic impact of Philip A. Iredale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Iredale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Iredale more than expected).

Fields of papers citing papers by Philip A. Iredale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Iredale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Iredale. The network helps show where Philip A. Iredale may publish in the future.

Co-authorship network of co-authors of Philip A. Iredale

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Iredale. A scholar is included among the top collaborators of Philip A. Iredale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Iredale. Philip A. Iredale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hadcock, John R., Philip A. Carpino, Philip A. Iredale, et al.. (2010). Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist. BMC Pharmacology. 10(1). 9–9. 12 indexed citations

Dow, Robert L., John R. Hadcock, Dennis O. Scott, et al.. (2009). Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles. Bioorganic & Medicinal Chemistry Letters. 19(18). 5351–5354. 11 indexed citations

Wise, Laura E., Philip A. Iredale, & Aron H. Lichtman. (2008). The cannabinoid CB1 receptor antagonist CE prolongs spatial memory duration in a rat delayed radial arm maze memory task. European Journal of Pharmacology. 590(1-3). 246–249. 17 indexed citations

Cao, Xuebing, Liang Li, John R. Hadcock, et al.. (2007). Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 323(1). 318–326. 82 indexed citations

Wise, Laura E., et al.. (2007). Combination of Rimonabant and Donepezil Prolongs Spatial Memory Duration. Neuropsychopharmacology. 32(8). 1805–1812. 43 indexed citations

Johnson, David E., Frank M. Nedza, Douglas K. Spracklin, et al.. (2004). The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. European Journal of Pharmacology. 506(3). 209–219. 32 indexed citations

Iredale, Philip A., Maura E. Charlton, John D. Alvaro, & Ronald S. Duman. (2003). Regulation of Receptor Expression: Analysis of Receptor mRNA and Gene Transcription. Humana Press eBooks. 83. 251–272.

Iredale, Philip A., John D. Alvaro, Young-Lim Lee, et al.. (2000). Role of Corticotropin‐Releasing Factor Receptor‐1 in Opiate Withdrawal. Journal of Neurochemistry. 74(1). 199–208. 82 indexed citations

Yan, Ni, Stephen J. Gold, Philip A. Iredale, et al.. (1999). Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies.. PubMed. 19(10). 3674–80. 82 indexed citations

10.

Li, Zhongwei, Vidita A. Vaidya, John D. Alvaro, et al.. (1998). Protein Kinase C-Mediated Down-Regulation of β1-Adrenergic Receptor Gene Expression in Rat C6 Glioma Cells. Molecular Pharmacology. 54(1). 14–21. 17 indexed citations

11.

Iredale, Philip A. & Ronald S. Duman. (1997). Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells. Molecular Pharmacology. 51(5). 794–799. 35 indexed citations

12.

Bundey, Richard A., et al.. (1997). Corticosteroid Modulation of Signal Transduction in the CATH.a Cell Line. Journal of Neurochemistry. 68(1). 362–369. 7 indexed citations

13.

Iredale, Philip A., Richard A. Bundey, & Ronald S. Duman. (1997). Phorbol Ester and Calcium Regulation of Corticotrophin‐Releasing Factor Receptor 1 Expression in a Neuronal Cell Line. Journal of Neurochemistry. 69(5). 1912–1919. 12 indexed citations

14.

Widnell, Katherine L., Jingshan Chen, Philip A. Iredale, et al.. (1996). Transcriptional Regulation of CREB (Cyclic AMP Response Element‐Binding Protein) Expression in CATH.a Cells. Journal of Neurochemistry. 66(4). 1770–1773. 24 indexed citations

15.

Iredale, Philip A., Keith F. Martin, Stephen J. Hill, & David A. Kendall. (1993). The control of intracellular calcium and neurotransmitter release in guinea pig-derived cerebral cortical synaptoneurosomes. Biochemical Pharmacology. 45(2). 407–414. 5 indexed citations

16.

Iredale, Philip A., et al.. (1993). The effects of β-phorbol-12,13 dibutyrate on agonist-induced increases in [Ca2+]i in N1E-115 cells. Biochemical Pharmacology. 45(3). 611–617. 2 indexed citations

17.

Iredale, Philip A., Hirokazu Fukui, & Stephen J. Hill. (1993). High, Stable Expression of the Bovine Histamine H1-Receptor Coupled to [Ca2+]i Mobilization in CHO-K1 Cells. Biochemical and Biophysical Research Communications. 195(3). 1294–1300. 12 indexed citations

18.

Iredale, Philip A., Keith F. Martin, Stephen J. Hill, & David A. Kendall. (1992). Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol. European Journal of Pharmacology Molecular Pharmacology. 226(2). 163–168. 20 indexed citations

19.

Iredale, Philip A., Keith F. Martin, S P H Alexander, Stephen J. Hill, & David A. Kendall. (1992). Qualitative differences in [Ca2+]i increases and InsP3 generation following stimulation of N1E-115 cells with micromolar and millimolar ATP. Biochemical Pharmacology. 44(8). 1479–1487. 7 indexed citations

20.

Iredale, Philip A., et al.. (1991). Histamine-induced changes in intracellular calcium in undifferentiated N1E-115 cells. Biochemical Society Transactions. 19(1). 6S–6S. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact